SCHEMBL22396381

SCHEMBL22396381

OC1CCC2(CC1)CC(O)C2

nearest known ligand 0.48

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22834514 0.83
SCHEMBL26984591 0.81
SCHEMBL23603996 0.80 ESR1 (0.48) ESR1ESR2
SCHEMBL12687548 0.80
SCHEMBL15680666 0.78
SCHEMBL12064525 0.78
SCHEMBL26721931 0.77
SCHEMBL26721949 0.77 ESR1 (0.36) ESR1ESR2TSHR
SCHEMBL23832316 0.75 ESR1 (0.39) ESR1ESR2TSHR
SCHEMBL16309022 0.75 TSHR (0.44) ESR1ESR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3704114-A1 SPIROCYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Bristol-Myers Squibb Company (US) 2020-09-09 EP disclosed